Skip to main content

Advertisement

Table 1 Relationship between CTD-2547G23.4 expression and clinical parameters in TCGA

From: Up-regulation of CTD-2547G23.4 in hepatocellular carcinoma tissues and its prospective molecular regulatory mechanism: a novel qRT-PCR and bioinformatics analysis study

Clinicopathological feature n CTD-2547G23.4 expression in TCGA database
M ± SD t P
Tissue
 Adjacent non-tumour tissues 50 14.5111 ± 8.3412 18.571 0.000
 HCC 370 48.7622 ± 27.2703
Gender
 Male 248 47.0800 ± 25.2880 1.696 0.091
 Female 122 52.1820 ± 30.7392
Neoplasm histologic grade
 G1 + G2 232 45.7392 ± 26.5334 − 3.028 0.003
 G3 + G4 134 54.6165 ± 27.8375
Pathologic stage
 Stage I–II 259 48.5259 ± 27.5527 − 0.779 0.437
 Stage III–IV 87 51.1969 ± 28.0238
Pathologic tumour
 TI–II 273 48.7915 ± 27.3716 − 0.114 0.910
 TIII–IV 93 49.1656 ± 27.4492
Pathologic lymph node
 No 252 48.7484 ± 28.3941 0.896 0.148
 Yes 4 69.5526 ± 31.8511
Metastasis
 No 266 48.5517 ± 27.1714 1.041 0.299
 Yes 4 34.3420 ± 19.3781
Person neoplasm cancer status
 Tumour free 202 46.8598 ± 26.3441 − 1.774 0.077
 With tumour 150 52.1074 ± 28.8736
Vascular tumour cell type
 Negative 205 45.8987 ± 25.3009 0.045 0.028
 Positive 110 53.5897 ± 31.4477